The Prophylactic Value of Ruxolitinib for aGVHD in HSCT Recipients of AA
1 clinical trials · Condition
◉ Watch The Prophylactic Value of Ruxolitinib for aGVHD in HSCT Recipients of AA
| Record | Firm | Date |
|---|---|---|
| Ruxolitinib as GVHD Prophylaxis in AA Patients (NCT05914714) | Institute of Hematology & Blood Diseases Hospital, China | 2023-07-01 |
Track The Prophylactic Value of Ruxolitinib for aGVHD in HSCT Recipients of AA automatically
Every clearance here is in the API, with alerts when new ones post.